1.
Jalil NJA, Bannur Z, Derahman A, Maskon O, Darinah N, Hamidi H, et al. The Implication of the Polymorphisms of COX-1, UGT1A6, and CYP2C9 among Cardiovascular Disease (CVD) Patients Treated with Aspirin. J Pharm Pharm Sci [Internet]. 2015 Sep. 30 [cited 2024 Nov. 25];18(3):474-83. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/24226